Activated and in-vitro-expanded NK cells show an increase in LGALS1 but not LGALS3 expression, whereas only LGALS1 is upregulated in AML cells compared to normal CD34+ HSC (Figure S3a,b). Here, LGALS1 is linked to acute myeloid leukemia.